High-throughput screen using a single-cell tyrosine phosphatase assay reveals biologically active inhibitors of tyrosine phosphatase CD45

Stephanie M. Stanford, Rekha G. Panchal, Logan M. Walker, Dennis J. Wu, Matthew D. Falk, Sayantan Mitra, Sagar S. Damle, David Ruble, Teodora Kaltcheva, Sheng Zhang, Zhong-Yin Zhang, Sina Bavari, Amy M. Barrios, Nunzio Bottini

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Many cellular signaling events are regulated by tyrosine phosphorylation and mediated by the opposing actions of protein tyrosine kinases and phosphatases. Protein tyrosine phosphatases are emerging as drug targets, but poor cell permeability of inhibitors has limited the development of drugs targeting these enzymes [Tautz L, et al. (2006) Expert Opin Ther Targets 10:157-177]. Here we developed a method to monitor tyrosine phosphatase activity at the single-cell level and applied it to the identification of cell-permeable inhibitors. The method takes advantage of the fluorogenic properties of phosphorylated coumaryl amino propionic acid (pCAP), an analog of phosphotyrosine, which can be incorporated into peptides. Once delivered into cells, pCAP peptides were dephosphorylated by protein tyrosine phosphatases, and the resulting cell fluorescence could be monitored by flow cytometry and high-content imaging. The robustness and sensitivity of the assay was validated using peptides preferentially dephosphorylated by CD45 and T-cell tyrosine phosphatase and available inhibitors of these two enzymes. The assay was applied to high-throughput screening for inhibitors of CD45, an important target for autoimmunity and infectious diseases [Hermiston ML, et al. (2003) Annu Rev Immunol 21:107-137]. We identified four CD45 inhibitors that showed activity in T cells and macrophages. These results indicate that our assay can be applied to primary screening for inhibitors of CD45 and of other protein tyrosine phosphatases to increase the yield of biologically active inhibitors.

Original languageEnglish
Pages (from-to)13972-13977
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume109
Issue number35
DOIs
StatePublished - Aug 28 2012

Fingerprint

Phosphoric Monoester Hydrolases
Protein Tyrosine Phosphatases
Tyrosine
Peptides
T-Lymphocytes
Phosphotyrosine
Enzyme Inhibitors
Drug Delivery Systems
Autoimmunity
Protein-Tyrosine Kinases
Communicable Diseases
Permeability
Flow Cytometry
Fluorescence
Macrophages
Phosphorylation
Enzymes
Pharmaceutical Preparations
propionic acid

Keywords

  • Peptide substrate
  • Single-cell assay

ASJC Scopus subject areas

  • General

Cite this

High-throughput screen using a single-cell tyrosine phosphatase assay reveals biologically active inhibitors of tyrosine phosphatase CD45. / Stanford, Stephanie M.; Panchal, Rekha G.; Walker, Logan M.; Wu, Dennis J.; Falk, Matthew D.; Mitra, Sayantan; Damle, Sagar S.; Ruble, David; Kaltcheva, Teodora; Zhang, Sheng; Zhang, Zhong-Yin; Bavari, Sina; Barrios, Amy M.; Bottini, Nunzio.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 109, No. 35, 28.08.2012, p. 13972-13977.

Research output: Contribution to journalArticle

Stanford, SM, Panchal, RG, Walker, LM, Wu, DJ, Falk, MD, Mitra, S, Damle, SS, Ruble, D, Kaltcheva, T, Zhang, S, Zhang, Z-Y, Bavari, S, Barrios, AM & Bottini, N 2012, 'High-throughput screen using a single-cell tyrosine phosphatase assay reveals biologically active inhibitors of tyrosine phosphatase CD45', Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 35, pp. 13972-13977. https://doi.org/10.1073/pnas.1205028109
Stanford, Stephanie M. ; Panchal, Rekha G. ; Walker, Logan M. ; Wu, Dennis J. ; Falk, Matthew D. ; Mitra, Sayantan ; Damle, Sagar S. ; Ruble, David ; Kaltcheva, Teodora ; Zhang, Sheng ; Zhang, Zhong-Yin ; Bavari, Sina ; Barrios, Amy M. ; Bottini, Nunzio. / High-throughput screen using a single-cell tyrosine phosphatase assay reveals biologically active inhibitors of tyrosine phosphatase CD45. In: Proceedings of the National Academy of Sciences of the United States of America. 2012 ; Vol. 109, No. 35. pp. 13972-13977.
@article{0b8bcab9d17549aa8df350f0c90c87de,
title = "High-throughput screen using a single-cell tyrosine phosphatase assay reveals biologically active inhibitors of tyrosine phosphatase CD45",
abstract = "Many cellular signaling events are regulated by tyrosine phosphorylation and mediated by the opposing actions of protein tyrosine kinases and phosphatases. Protein tyrosine phosphatases are emerging as drug targets, but poor cell permeability of inhibitors has limited the development of drugs targeting these enzymes [Tautz L, et al. (2006) Expert Opin Ther Targets 10:157-177]. Here we developed a method to monitor tyrosine phosphatase activity at the single-cell level and applied it to the identification of cell-permeable inhibitors. The method takes advantage of the fluorogenic properties of phosphorylated coumaryl amino propionic acid (pCAP), an analog of phosphotyrosine, which can be incorporated into peptides. Once delivered into cells, pCAP peptides were dephosphorylated by protein tyrosine phosphatases, and the resulting cell fluorescence could be monitored by flow cytometry and high-content imaging. The robustness and sensitivity of the assay was validated using peptides preferentially dephosphorylated by CD45 and T-cell tyrosine phosphatase and available inhibitors of these two enzymes. The assay was applied to high-throughput screening for inhibitors of CD45, an important target for autoimmunity and infectious diseases [Hermiston ML, et al. (2003) Annu Rev Immunol 21:107-137]. We identified four CD45 inhibitors that showed activity in T cells and macrophages. These results indicate that our assay can be applied to primary screening for inhibitors of CD45 and of other protein tyrosine phosphatases to increase the yield of biologically active inhibitors.",
keywords = "Peptide substrate, Single-cell assay",
author = "Stanford, {Stephanie M.} and Panchal, {Rekha G.} and Walker, {Logan M.} and Wu, {Dennis J.} and Falk, {Matthew D.} and Sayantan Mitra and Damle, {Sagar S.} and David Ruble and Teodora Kaltcheva and Sheng Zhang and Zhong-Yin Zhang and Sina Bavari and Barrios, {Amy M.} and Nunzio Bottini",
year = "2012",
month = "8",
day = "28",
doi = "10.1073/pnas.1205028109",
language = "English",
volume = "109",
pages = "13972--13977",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "35",

}

TY - JOUR

T1 - High-throughput screen using a single-cell tyrosine phosphatase assay reveals biologically active inhibitors of tyrosine phosphatase CD45

AU - Stanford, Stephanie M.

AU - Panchal, Rekha G.

AU - Walker, Logan M.

AU - Wu, Dennis J.

AU - Falk, Matthew D.

AU - Mitra, Sayantan

AU - Damle, Sagar S.

AU - Ruble, David

AU - Kaltcheva, Teodora

AU - Zhang, Sheng

AU - Zhang, Zhong-Yin

AU - Bavari, Sina

AU - Barrios, Amy M.

AU - Bottini, Nunzio

PY - 2012/8/28

Y1 - 2012/8/28

N2 - Many cellular signaling events are regulated by tyrosine phosphorylation and mediated by the opposing actions of protein tyrosine kinases and phosphatases. Protein tyrosine phosphatases are emerging as drug targets, but poor cell permeability of inhibitors has limited the development of drugs targeting these enzymes [Tautz L, et al. (2006) Expert Opin Ther Targets 10:157-177]. Here we developed a method to monitor tyrosine phosphatase activity at the single-cell level and applied it to the identification of cell-permeable inhibitors. The method takes advantage of the fluorogenic properties of phosphorylated coumaryl amino propionic acid (pCAP), an analog of phosphotyrosine, which can be incorporated into peptides. Once delivered into cells, pCAP peptides were dephosphorylated by protein tyrosine phosphatases, and the resulting cell fluorescence could be monitored by flow cytometry and high-content imaging. The robustness and sensitivity of the assay was validated using peptides preferentially dephosphorylated by CD45 and T-cell tyrosine phosphatase and available inhibitors of these two enzymes. The assay was applied to high-throughput screening for inhibitors of CD45, an important target for autoimmunity and infectious diseases [Hermiston ML, et al. (2003) Annu Rev Immunol 21:107-137]. We identified four CD45 inhibitors that showed activity in T cells and macrophages. These results indicate that our assay can be applied to primary screening for inhibitors of CD45 and of other protein tyrosine phosphatases to increase the yield of biologically active inhibitors.

AB - Many cellular signaling events are regulated by tyrosine phosphorylation and mediated by the opposing actions of protein tyrosine kinases and phosphatases. Protein tyrosine phosphatases are emerging as drug targets, but poor cell permeability of inhibitors has limited the development of drugs targeting these enzymes [Tautz L, et al. (2006) Expert Opin Ther Targets 10:157-177]. Here we developed a method to monitor tyrosine phosphatase activity at the single-cell level and applied it to the identification of cell-permeable inhibitors. The method takes advantage of the fluorogenic properties of phosphorylated coumaryl amino propionic acid (pCAP), an analog of phosphotyrosine, which can be incorporated into peptides. Once delivered into cells, pCAP peptides were dephosphorylated by protein tyrosine phosphatases, and the resulting cell fluorescence could be monitored by flow cytometry and high-content imaging. The robustness and sensitivity of the assay was validated using peptides preferentially dephosphorylated by CD45 and T-cell tyrosine phosphatase and available inhibitors of these two enzymes. The assay was applied to high-throughput screening for inhibitors of CD45, an important target for autoimmunity and infectious diseases [Hermiston ML, et al. (2003) Annu Rev Immunol 21:107-137]. We identified four CD45 inhibitors that showed activity in T cells and macrophages. These results indicate that our assay can be applied to primary screening for inhibitors of CD45 and of other protein tyrosine phosphatases to increase the yield of biologically active inhibitors.

KW - Peptide substrate

KW - Single-cell assay

UR - http://www.scopus.com/inward/record.url?scp=84865538949&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865538949&partnerID=8YFLogxK

U2 - 10.1073/pnas.1205028109

DO - 10.1073/pnas.1205028109

M3 - Article

C2 - 22891353

AN - SCOPUS:84865538949

VL - 109

SP - 13972

EP - 13977

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 35

ER -